Date: 21.5.2021
An international research team led by Professor Charles Gauthier from the Institut national de la recherche scientifique (INRS) has discovered a new molecule with potential to revolutionize the biosurfactant market.
Surfactants are synthesized from petroleum and are the main active ingredient in most soaps, detergents, and shampoos. Biosurfactants, produced by bacteria, are safer and can replace synthetic surfactants.
Rhamnolipid molecules are some of the safest surfactants known and are particularly attractive, thanks to their biodegradability, minimal toxicity, and amenability to be produced from industrial waste. But there's a problem. They are made using Pseudomonas aeruginosa, a pathogenic bacterium harmful to humans.
"If we want to fully gain the benefits of rhamnolipids, we need to grow these pathogenic bacteria on a huge scale. And because that's a health risk, the industry is looking for alternatives," explained Professor Gauthier. The molecules produced by these bacteria are usually mixed with other compounds or virulence factors, making them trickier to use.
To address the problem, the research team identified molecules that resemble rhamnolipids in Pantoea ananatis, a non-pathogenic bacterium. The team was then able to chemically synthesize these molecules, called ananatosides, in the laboratory, raising the possibility that they could be produced on a larger scale than using bacteria. The industry is already showing interest in these promising new biosurfactants.
Gate2Biotech - Biotechnology Portal - All Czech Biotechnology information in one place.
ISSN 1802-2685
This website is maintained by: CREOS CZ
© 2006 - 2024 South Bohemian Agency for Support to Innovative Enterprising (JAIP)
Interesting biotechnology content:
Africa Biotech - Biotechnology and African Agriculture news
Biotechnology Books no. 14 - 14th page of aour database of biotechnology books
CRISPR/Cas9 modifies Euglena to create potential biofuel source
Tick-borne red meat allergy prevented in mice through new nanoparticle treatment